Access Resources
Thank you for your interest in our resources. Please fill out the information here to have full access to our library of useful information, including what you are looking for currently.
← Return to ResourcesRelated Content
Antibody-drug conjugates (ADCs) hold great promise as targeted cancer therapeutics, but their complex structure poses significant development and safety challenges....
VIEW RESOURCEIndoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that metabolizes tryptophan, and its activity can lead to immunosuppression, thereby allowing tumors...
VIEW RESOURCE